3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Lymphoma, Non-Hodgkin
5
Lymphoma
4
Cardiotoxicity
4
Heart Failure
3
Prostatic Neoplasms
2
Heart Diseases
2
Breast Neoplasms
2
Ventricular Dysfunction, Left
1
Thoracic Neoplasms
1
Small Cell Lung Carcinoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Philadelphia Chromosome
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Metastatic Solid Tumors
1
Metabolic Syndrome
1
Memory Disorders
1
Lymphoproliferative Disorders
1
Lymphomatoid Granulomatosis
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Follicular
1
Lymphoma, B-Cell
1
Lung Neoplasms
1
Leukemia, B-Cell
1
Leukemia
1
Hodgkin Disease
1
Hereditary Breast and Ovarian Cancer Syndrome
1
Hematologic Neoplasms
1
Epstein-Barr Virus Infections
1
Interventions
Metformin
2
Ethinyl Estradiol
2
Blood Pressure
2
drospirenone and ethinyl estradiol combination
1
drospirenone
1
Vascular Stiffness
1
Ultrasonography
1
Triptorelin Pamoate
1
Testosterone
1
Sugars
1
Spironolactone
1
Pulse Wave Analysis
1
Preoperative Exercise
1
Phlebotomy
1
Orchiectomy
1
Medical History Taking
1
Magnetic Resonance Spectroscopy
1
Inositol
1
Human Growth Hormone
1
Hematologic Tests
1
Growth Hormone
1
Flutamide
1
Exercise
1
Etanercept
1
Electrocardiography
1
Echocardiography
1
Diet, Reducing
1
Diet, Mediterranean
1
Diet, Fat-Restricted
1
Diet Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Metabolic Syndrome
×
Echocardiography
×
Clear all
NCT07041827
2025-06-27
CLARITY
The Netherlands Cancer Institute
Completed
217 enrolled